These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue. Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Shimizu J; Murahashi Y; Emori M; Hasegawa T Diagn Pathol; 2022 Nov; 17(1):88. PubMed ID: 36320082 [TBL] [Abstract][Full Text] [Related]
5. A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor. Lipplaa A; Meijer D; van de Sande MAJ; Gelderblom H; Bovée JVMG; Mei H; Szuhai K Genes Chromosomes Cancer; 2023 Apr; 62(4):223-230. PubMed ID: 36504457 [TBL] [Abstract][Full Text] [Related]
6. Intramuscular Tenosynovial Giant Cell Tumor Harboring a Novel Mejbel H; Siegal GP; Wei S Int J Surg Pathol; 2022 May; 30(3):335-338. PubMed ID: 34657489 [TBL] [Abstract][Full Text] [Related]
7. Detection of CSF1 rearrangements deleting the 3' UTR in tenosynovial giant cell tumors. Ho J; Peters T; Dickson BC; Swanson D; Fernandez A; Frova-Seguin A; Valentin MA; Schramm U; Sultan M; Nielsen TO; Demicco EG Genes Chromosomes Cancer; 2020 Feb; 59(2):96-105. PubMed ID: 31469468 [TBL] [Abstract][Full Text] [Related]
8. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. West RB; Rubin BP; Miller MA; Subramanian S; Kaygusuz G; Montgomery K; Zhu S; Marinelli RJ; De Luca A; Downs-Kelly E; Goldblum JR; Corless CL; Brown PO; Gilks CB; Nielsen TO; Huntsman D; van de Rijn M Proc Natl Acad Sci U S A; 2006 Jan; 103(3):690-5. PubMed ID: 16407111 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation. Huang HY; West RB; Tzeng CC; van de Rijn M; Wang JW; Chou SC; Huang WW; Eng HL; Lin CN; Yu SC; Wu JM; Lu CC; Li CF Clin Cancer Res; 2008 Oct; 14(19):6023-32. PubMed ID: 18829481 [TBL] [Abstract][Full Text] [Related]
10. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089 [TBL] [Abstract][Full Text] [Related]
11. Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene. Brahmi M; Alberti L; Tirode F; Karanian M; Eberst L; Pissaloux D; Cassier P; Blay JY Ann Oncol; 2018 Jun; 29(6):1488-1489. PubMed ID: 29668829 [No Abstract] [Full Text] [Related]
12. Panagopoulos I; Gorunova L; Lobmaier I; Andersen K; Kostolomov I; Lund-Iversen M; Bjerkehagen B; Heim S Cancer Genomics Proteomics; 2020; 17(2):161-168. PubMed ID: 32108038 [TBL] [Abstract][Full Text] [Related]
15. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Panagopoulos I; Mertens F; Dêbiec-Rychter M; Isaksson M; Limon J; Kardas I; Domanski HA; Sciot R; Perek D; Crnalic S; Larsson O; Mandahl N Int J Cancer; 2002 Jun; 99(4):560-7. PubMed ID: 11992546 [TBL] [Abstract][Full Text] [Related]
16. Diffuse-type tenosynovial giant cell tumor with t(1;17)(p13;p13) and trisomy 5. Nishio J; Kamachi Y; Iwasaki H; Naito M In Vivo; 2014; 28(5):949-52. PubMed ID: 25189912 [TBL] [Abstract][Full Text] [Related]
17. Tenosynovial Giant Cell Tumor, Localized Type With Extensive Chondroid Metaplasia: A Case Report With Immunohistochemical and Molecular Genetic Analysis. Nagase M; Araki A; Ishikawa N; Nagano N; Fujimoto M; Biyajima K; Yamagami N; Yamamoto S; Maruyama R Int J Surg Pathol; 2020 Jun; 28(4):447-453. PubMed ID: 31771368 [TBL] [Abstract][Full Text] [Related]
18. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee? Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874 [TBL] [Abstract][Full Text] [Related]
19. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases. Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541 [TBL] [Abstract][Full Text] [Related]
20. S100A10 is required for the organization of actin stress fibers and promotion of cell spreading. Sayeed S; Asano E; Ito S; Ohno K; Hamaguchi M; Senga T Mol Cell Biochem; 2013 Feb; 374(1-2):105-11. PubMed ID: 23129259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]